Mirati Therapeutics
MRTX
#3099
Rank
NZ$6.65 B
Marketcap
$94.88
Share price
0.00%
Change (1 day)
44.33%
Change (1 year)

Mirati Therapeutics (MRTX) - Cash on Hand

Cash on Hand as of September 2023 : NZ$1.57 B

According to Mirati Therapeutics's latest financial reports the company has NZ$1.57 B in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Mirati Therapeutics - Cash on Hand chart (from 2005 to 2023)

Cash on Hand by year

Year Cash on Hand Change
2022-12-31NZ$1.70 B-21.61%
2021-12-31NZ$2.17 B12.66%
2020-12-31NZ$1.93 B214.14%
2019-12-31NZ$0.61 B85.33%
2018-12-31NZ$0.33 B56.31%
2017-12-31NZ$0.21 B159.31%
2016-12-31NZ$81.9 M-54.23%
2015-12-31NZ$0.17 B379.02%
2014-12-31NZ$37.35 M-50.57%
2013-12-31NZ$75.57 M67.54%
2012-12-31NZ$45.11 M24.26%
2011-12-31NZ$36.3 M279.02%
2010-12-31NZ$9.57 M-58.58%
2009-12-31NZ$23.12 M-57.94%
2008-12-31NZ$54.98 M-30.72%
2007-12-31NZ$79.36 M-0.92%
2006-12-31NZ$80.1 M142.48%
2005-12-31NZ$33.03 M-31.58%
2004-12-31NZ$48.28 M32.09%
2003-12-31NZ$36.55 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
NZ$0.62 B-60.48%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.21 M-99.99% Bahamas